Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 New Entrants companies in Carbonic anhydrase inhibitor
by Most Patent Filing In 5 Years in the world in 2020

The Carbonic anhydrase inhibitor top 20 is Discovery PatSnap’ annual ranking of the top 20 Most Patent Filing In 5 Years Carbonic anhydrase inhibitor New Entrants in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2020, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Carbonic anhydrase inhibitors are a class of pharmaceuticals that suppress the activity of carbonic anhydrase. Their clinical use has been established as anti-glaucoma agents, diuretics, antiepileptics, in the management of mountain sickness, gastric and duodenal ulcers, idiopathic intracranial hypertension, neurological disorders, or osteoporosis.
#
Company Name
Region
Tech Topics
Total
1
Medicine,Health care,Glaucoma,
...[+2]
Patent: 17
2
Patent: 5
3
Medicine,Health care,Drug,
...[+2]
Patent: 4
4
HaMerkaz, Israel
Association (object-oriented programming),Intellectual property,Biotechnology,
...[+2]
Patent: 4
5
Medicine,Health care,Biopharmaceutical,
...[+2]
Patent: 3
6
Jerusalem, Israel
Health care,Technology transfer,Biomedicine,
...[+2]
Patent: 3
7
Patent: 2
8
South Korea
Emergency department,Healthcare system,Medical tourism,
...[+2]
Patent: 2
9
History of the United States,Bequest,Medicine,
...[+2]
Patent: 2
10
Patent: 2
11
Patent: 2
12
Queensland, Australia
Asian studies,Library science,Digital library,
...[+2]
Patent: 2
13
Health care,Mitral valve surgery,Health equity,
...[+2]
Patent: 2
14
Ontario, Canada
Patent: 2
15
Financial asset,Technology transfer,Incubation,
...[+2]
Patent: 2
16
Latvia
Patent: 1
17
Patent: 1
18
Patent: 1
19
Health care,Library science,Medicine,
...[+2]
Patent: 1
20
Patent: 1
Page generation time: Apr 29 2025